A Chinese biotech that became popular by co-developing an anti-Covid drug has filed for a Hong Kong stock market listing.
16d
Best Life on MSNCOVID's "Extreme Inflammatory Response" Can Hurt Your Heart, New Research ShowsScientists are still trying to wrap their heads around the effects of long COVID, which data shows is affecting more than 1 million children and 20 million adults in the U.S. Common long-COVID ...
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...
A deluge of disinformation about a flu-like virus called HMPV is stoking anti-China sentiment across Asia and spurring ...
The British broadcaster's footage shows clashes between police and residents in Shanghai, China as the city entered its third week of strict Covid-19 lockdowns. Screenshot comparison of the image ...
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...
The Wuhan Institute of Virology was not involved in the creation or leakage of the COVID-19 virus, a spokesperson of China's ...
Researchers in Hong Kong found that increased cleaning during the Covid-19 pandemic may have caused a 46 per cent rise in ...
With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. In a small study, patients with the syndrome were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results